本文言語 | 英語 |
---|---|
ページ(範囲) | 596-598 |
ページ数 | 3 |
ジャーナル | Psychiatry and clinical neurosciences |
巻 | 76 |
号 | 11 |
DOI | |
出版ステータス | 出版済み - 11-2022 |
All Science Journal Classification (ASJC) codes
- 神経科学一般
- 神経学
- 臨床神経学
- 精神医学および精神衛生
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
文献へのアクセス
他のファイルとリンク
引用スタイル
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Psychiatry and clinical neurosciences, Vol. 76, No. 11, 11.2022, p. 596-598.
研究成果: ジャーナルへの寄稿 › Letter › 査読
TY - JOUR
T1 - Proportion of subjects with psychotic features in bipolar disorder correlated with treatment response by antipsychotics for acute mania
AU - Ikeda, Masashi
AU - Saito, Takeo
AU - Kanazawa, Tetsufumi
AU - Kishi, Taro
AU - Iwata, Nakao
N1 - Funding Information: We thank Dr. Gary Sachs and AbbVie Inc. for providing the unpublished information about their study. The authors also thank MARUZEN‐YUSHODO Co., Ltd. ( https://kw.maruzen.co.jp/kousei-honyaku/ ) for the English language editing. This study was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Numbers JP20dm0107097 (NI, MI and TS), JP22wm0425008 (NI, MI and TS), and JP22wm0525024 (MI and TKishi); GRIFIN of P3GM from AMED under Grant Numbers JP20km0405201 (TS and NI), JP20km0405208 (MI), and JP22tm0424220 (MI); AMED under Grant Number JP22dk0307107 (TKishi); Health and Labor Sciences Research Grant under Grant Number 21GC1018 (TKishi); JSPS Kakenhi Grant Numbers JP21H02854 (MI), JP21K07490 (TS), and JP19K08082 (TKishi); and the Private University Research Branding Project from MEXT (NI). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: We thank Dr. Gary Sachs and AbbVie Inc. for providing the unpublished information about their study. The authors also thank MARUZEN-YUSHODO Co., Ltd. (https://kw.maruzen.co.jp/kousei-honyaku/) for the English language editing. This study was supported by the Japan Agency for Medical Research and Development (AMED) under Grant Numbers JP20dm0107097 (NI, MI and TS), JP22wm0425008 (NI, MI and TS), and JP22wm0525024 (MI and TKishi); GRIFIN of P3GM from AMED under Grant Numbers JP20km0405201 (TS and NI), JP20km0405208 (MI), and JP22tm0424220 (MI); AMED under Grant Number JP22dk0307107 (TKishi); Health and Labor Sciences Research Grant under Grant Number 21GC1018 (TKishi); JSPS Kakenhi Grant Numbers JP21H02854 (MI), JP21K07490 (TS), and JP19K08082 (TKishi); and the Private University Research Branding Project from MEXT (NI). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PY - 2022/11
Y1 - 2022/11
UR - http://www.scopus.com/inward/record.url?scp=85137777858&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137777858&partnerID=8YFLogxK
U2 - 10.1111/pcn.13460
DO - 10.1111/pcn.13460
M3 - Letter
C2 - 35962651
AN - SCOPUS:85137777858
SN - 1323-1316
VL - 76
SP - 596
EP - 598
JO - Psychiatry and clinical neurosciences
JF - Psychiatry and clinical neurosciences
IS - 11
ER -